<DOC>
	<DOCNO>NCT00930566</DOCNO>
	<brief_summary>ECP give patient [ UVAR®XTS TM Therakos system , Johnson &amp; Johnson ] accord follow schedule : Starting day 21 transplant , hematologic recovery allow : 2 ECP per week first 2 week , 1 ECP per week 1 month . Total = 8 ECP transplantation .</brief_summary>
	<brief_title>Extracorporal Photopheresis Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Methoxsalen</mesh_term>
	<criteria>Patients ≥ 18 year &lt; = 65 year hematological malignancy indicate allogeneic transplantation reduce intensity conditioning : due age : patient 55 65 year . patient 18 55 year age present risk increase toxicity myeloablative conditioning ( cardiac , renal pulmonary pathology ) CML MPS blastic phase achieve CR , MM stage II III , relapse autologous transplant , achieve response ≥ 30 % first line high risk , NHL 2nd CR , PR chemotherapy autologous transplant , chemosensible . CLL 2nd CR , PR chemotherapy autologous transplant , chemosensible . AML 2nd CR first line high risk criterion , secondary AML . In AML , high risk criterion define : LAM 7 , leukocytes &gt; 30000/mm3 , cytogenetic abnormality : ( 6,9 ) ; 11q23 , 17p , 11q , 20q , 21q , 5 , del ( 5q ) , 7/del7q , del 9q inv 3q , ALL 2nd CR first line high risk criterion define cytogenetic abnormality : 11q23 , ( 9,22 ) ; ( 1,19 ) ; ( 4,11 ) . MDS patient without prior chemotherapy HLA identical sibling donor Performans status &lt; = 2 Patients member social security company Age &lt; 18 year &gt; 65 year Pregnant lactating female Known HIV positivity Active infectious hepatitis , type A , B C Performance status &gt; 2 accord WHO Left ventricular ejection fraction &lt; 40 % Alveoluscapillary diffusion &lt; 50 % Uncontrollable hypertension medical therapy Creatinine clearance &lt; 60 ml/min Hypersensitivity allergy psoralen ( methoxsalen ) Disease associate photosensitivity Hypersensitivity allergy heparin citrate product Contraindication Busulfan , Fludarabine , SAT methotrexate Hypersensitivity ciclosporine , mycophenolate mofetil mycophenolic acid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Allogeneic Hematopoietic Stem Cell Transplantation</keyword>
	<keyword>Extracorporeal Photopheresis</keyword>
</DOC>